This volume aims to build a new generation of experts with a broader understanding of key
topics in the Alzheimer's disease field. Chapters guide readers through innovative approaches
to the discovery of novel biomarkers in cerebrospinal fluid innovation in blood-based
biomarkers a comprehensive overview of magnetic resonance imaging and molecular imaging
approaches and their value for developing drugs for Alzheimer's disease cutting-edge
developments in neuropathology and their relevance for Alzheimer's disease trials novel
genomic strategies for biomarker development and related topics including neuropsychological
testing and advanced analytical methods.Written in the highly successful Methods in Molecular
Biology series format chapters include introductions to their respective topics lists of the
necessary materials and reagents step-by-step readily reproducible laboratory protocols and
tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge Biomarkers
for Alzheimer's Disease Drug Development aims to ensure successful results in the further study
of this vital field.